The biological activity, also on other targets (115), was not diminished, and liraglutide has also been approved for obesity treatment (116)
Insurance companies therefore either elect to exclude GLP-1 drugs from their drug formulary, or create barriers to accessing them
Medications in pill forms are also cheaper to manufacture, which in theory, would make these drugs cheaper for consumers
Im Flora Lichtman, and youre listening to Science Friday
It is worth screening for
I believe I meet the clinical criteria" "I have tried [specific methods] for [duration] with [results]" "I understand the side effect profile and am prepared to manage them" "Which option would you recommend given my specific health profile and insurance coverage?" That last phrase is perhaps the most important one in this entire guide